Importantly, neither Roxadustat nor Vadadustat affected the proliferation of CD8 + T cells or MSS colon cancer model cells, including human SW480 and HT29 cells and the murine Colon26 cells (Fig. 1 B-C and S1D) [12, 13]. The gene discussed is CD8A; the disease is colonic neoplasm.